APOLLOHOSP Charts, Analysis and Tips

home > pharma-and-healthcare > hospitals-and-medical-services > apollohosp

Technical Analysis

Technical Strength: 4 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 48.5. According to RSI analysis, apollohosp is marginally weak. 4.0 APOLLOHOSP RSI Chart
MACD (?) MACD: -7.74 and Signal Line: -1.21. According to MACD analysis, apollohosp is technically weak. 2.0 APOLLOHOSP MACD Chart
Simple Moving Average (?) According to simple moving average analysis, apollohosp is facing resistance from it's 20-day simple moving average at 1137.87 and support level is at 1.11e+03. 8.0 APOLLOHOSP Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, apollohosp is facing resistance from it's 20-day exponential moving average at 1123.448 and support level is at 1.11e+03. 3.0 APOLLOHOSP Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.347. 5.0 APOLLOHOSP Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above 61.8% and 50% level. Support is at 1092.075 and 1060.9289. Resistance level is 1123.2211. 8.0 APOLLOHOSP Fibonacci Retracement Chart
Average True Range (?) ATR: 39.3 NA APOLLOHOSP Average True Range Chart
Average Directional Index (?) ADX is 22.5 which means APOLLOHOSP is in a trading range and there is no trend. NA APOLLOHOSP Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Stock Price - NSE
October 01, 2014
Open Price 1130.0
High Price 1150.5
Low Price 1103.1
Close Price 1115.6
Absolute Change -5.1
Percentage Change -0.455%
Weekly Change 2.46%
Monthly Change -5.76%
Yearly Change 20.9%
52-week high 1224.05
52-week low 815.35
Corporate Actions
ExDate Purpose
August 13, 2014 AGM/DIV-RS.5.75 PER SHARE
July 25, 2013 AGM/DIV-RS.5.50 PER SHARE
July 26, 2012 AGM/DIV RS 4 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.454
Confidence in Beta0.648%
Market Capital Rs. 15521.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 24.05
TTM Price-to-Earnings (P/E) Ratio 46.4
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 01 October 2014: Deliverable Quantity:4.49e+04 NA APOLLOHOSP Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 01 October 2014: Daily Volatility:0.4356 NA APOLLOHOSP Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 01 October 2014: PCR_OI:0.45 PCR:0.421 NA APOLLOHOSP PCR Chart
Premium (?) 01 October 2014 Premium: 5.95 Futures OI:311250.0 NA APOLLOHOSP Premium Chart
Option_MAX_OI (?) 01 October 2014: Price:1115.6 Put with maximum OI:1100.0 Call with maximum OI:1200.0 NA APOLLOHOSP Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
October 30, 2014 1121.55 311250.0 514.0 523.0 1115.6
November 27, 2014 1157.3 500.0 3.0 3.0 1115.6

Option Chains - NSE

Call Volatility Smile Chart
Put Volatility Smile Chart
Submit to find prices and greeks (delta, gamma, theta, vega, rho) of apollohosp options for different expiry dates. (What are option greeks?)


October 01, 2014 Press Release Apollo Hospitals Enterprise Limited has informed the Exchange regarding a press release dated September 30,2014 titled " Apollo Hospitals and Sanofi announce collaboration to provide an integrated care program in India for people with diabetes ".
September 17, 2014 News Clarification The Exchange sought clarification from Apollo Hospitals Enterprise Limited with respect to a news item captioned "Apollo Hospitals ties up with US firm for mobile ECG devices". The Company has clarified that "Apollo Hospitals Enterprise Limited has signed a MOU with AliveCor (a US based Company) to tackle the growing problem of heart arrhythmia by empowering patients to check their heart health anywhere, anytime whereby AliveCor will provide their innovative mobile ECG devices as part of an Apollo branded arrhythmia screening and stroke prevention program. The device, developed and patented by AliveCor, is attached to mobile devices working on iOS and Android platforms. It helps individuals screen the incidence of heart arrhythmias (HA), associated with irregular heartbeat. It weighs ~ 40-50 g, captures the heartbeat of patients through finger impression and wirelessly records, displays, stores and transfers the heart rate and single channel electrocardiogram (ECG). The captured data, after passing through select algorithms, is interpreted by back-end healthcare teams analysing the ECG continuously and transmitting them to patients 24 hours a day. This in a way helps patients detected with HA and also others at risk to monitor the sudden changes in heartbeat and thereby leading to early diagnosis and better disease management. Cleared by the USFDA, AliveCor Heart Monitor is being marketed online for $200 in India. Apollo Through a group entity HealthNet Global, Apollo Hospitals plans to deliver the interpretative services to its patients. The service would be initially priced at Rs 1,000 a month. We do not expect any material impact to the Company , due to this development. There are no other relevant disclosures to be made".
See all Announcements

Board Meetings

Date Meeting Date Purpose
July 22, 2014 August 12, 2014 Results to consider inter alia, approve and take on record unaudited financial results of the Company for the quarter ended June 30, 2014.
May 19, 2014 May 28, 2014 Results/Dividend To consider inter alia:- (i) The Audited Financial Results of the Company for the quarter/year ended 31st March 2014. (ii) The Audited Consolidated Financial Results of the Company and its subsidiaries, Joint Ventures and Associate Companies for the year ended 31st March 2014. (iii) To recommend a dividend, if any, for the financial year ended 31st March 2014.
See all Board Meetings

APOLLOHOSP is part of...

Index Weightage
CNX100 0.28
CNX500 0.24

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 1048 Rs. 1076 Rs. 1096 Rs. 1123 Rs. 1143 Rs. 1170 Rs. 1190